The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable
cardioverter-defibrillator
by Guiqing Yao, Nick Freemantle, Melanie J. Calvert, Stirling Bryan, Jean-Claude Daubert, and John G.F. Cleland
EHJVolume 28(1):42-51January 12, 2007
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
Structure of short term model.
Guiqing Yao et al. Eur Heart J 2007;28:42-51
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
Structure of long-term model (NYHA class I).
Guiqing Yao et al. Eur Heart J 2007;28:42-51
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
Model predicted survival curves for MT, CRT-P, and CRT–ICD.
Guiqing Yao et al. Eur Heart J 2007;28:42-51
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
(A) Cost-effectiveness acceptability curves of CRT (+/ − ICD) vs.
Guiqing Yao et al. Eur Heart J 2007;28:42-51
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
Incremental cost per QALY gained by different starting age at treatment (in EUROs).
Guiqing Yao et al. Eur Heart J 2007;28:42-51
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
Model predicting survival with the CARE-HF trial age matched cohort and the trial based Kaplan–Meier estimates of survival curves.
Guiqing Yao et al. Eur Heart J 2007;28:42-51
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: [email protected]
Top Related